Dapoxetine hydrochloride CAS 129938-20-1
Introduction:Basic information about Dapoxetine hydrochloride CAS 129938-20-1, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Dapoxetine hydrochloride Basic information
| Product Name: | Dapoxetine hydrochloride |
| Synonyms: | DL-Dapoxteine HCL;N,N-DiMethyl-1-phenyl-3-(1-naphthalenyloxy)propanaMinehydrochloride;(S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride;Dapoxetine/Dapoxetine HCl/Dapoxetine hydrochloride;LY-210448 hydrochloride;Priligy;PRILIGY;LY-210448 HYDROCHLORIDE;(S)-N,N-dimethyl-3- |
| CAS: | 129938-20-1 |
| MF: | C21H24ClNO |
| MW: | 341.88 |
| EINECS: | 640-411-8 |
| Product Categories: | Amines;Aromatics;Inhibitors;Dapoxetine Hydrochloride;Intermediates & Fine Chemicals;Pharmaceuticals;API;129938-20-1 |
| Mol File: | 129938-20-1.mol |
Dapoxetine hydrochloride Chemical Properties
| Melting point | 175-1790C |
| alpha | D +135.78° (c = 2.18 in methanol) |
| storage temp. | room temp |
| solubility | DMSO: ≥20mg/mL |
| form | powder |
| color | white |
| Optical Rotation | [α]/D +125 to +135°, c = 1 in methanol |
| Merck | 14,2821 |
| InChI | InChI=1/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H/t20-;/s3 |
| InChIKey | IHWDIQRWYNMKFM-OZYVVJTJNA-N |
| SMILES | O(C1=CC=CC2C=CC=CC1=2)CC[C@@H](C1C=CC=CC=1)N(C)C.Cl |&1:13,r| |
| CAS DataBase Reference | 129938-20-1(CAS DataBase Reference) |
Safety Information
| Hazard Codes | Xn,N |
| Risk Statements | 22-36-50/53 |
| Safety Statements | 36-60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | 3 |
| HS Code | 29221990 |
| Storage Class | 11 - Combustible Solids |
| Hazard Classifications | Acute Tox. 4 Oral Aquatic Chronic 4 Eye Irrit. 2 |
| Description | Dapoxetine hydrochloride, belonging to the class of SSRIs, was the first drug originally approved for the on-demand treatment of men with PE by seven European countries in 2008. Premature ejaculation (PE) is the most common male sexual dysfunction. Dapoxetine is a short-acting SSRI. It is differentiated from the existing SSRI treatments for PE by the fact that it can be administered on an as-needed basis. In healthy subjects, dapoxetine is rapidly absorbed after oral administration with a peak plasma concentration (Tmax) occurring between 1.4 and 2h. |
| Chemical Properties | Dapoxetine hydrochloride is a white to slightly yellow powder. It is freely soluble in methanol, propylene glycol, some organic solvents (eg. N,N-dimethylformamide) , slightly soluble in ethanol and almost insoluble in water. It is a BCSI class II compound, and poor solubility is a key factor affecting the difference in clinical efficacy. Dapoxetine hydrochloride exists in various crystal forms, the solubility of different crystal forms is quite different, and there is a phenomenon of phase and transformation between crystal forms. |
| Originator | Lilly (US) |
| Uses | Dapoxetine hydrochloride is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men. |
| Brand name | Priligy |
| General Description | Dapoxetine ((+)-(S)-N,N-dimethyl-(α)-[2(1naphthal enyloxy)ethyl]-benzenemethanamine hydrochloride) possess a similar structure as that of fluoxetine. |
| Biochem/physiol Actions | Potent Selective serotonin reuptake inhibitor (SSRI); used in treatment of premature ejaculation |
| Synthesis | Dapoxetine can be synthesized in four chemical steps starting from R-1phenyl-1,3-propanediol via selective tosylation of the primary hydroxygroup with p-toluenesulfonyl chloride, triethylamine and 4-(dimethylamino)pyridine (DMAP), and subsequent condensation with 1naphtholby means of sodium- or lithium hydroxide to yield R-3-(1naphthyloxy)-1-phenylpropanol as the key intermediate. Conversion ofthe alcohol group to the corresponding mesylate with methanesulfonylchloride, triethylamine, and DMAP, followed by treatment withdimethylamine affords dapoxetine, which is then acidified to its hydrochloridesalt. |
| storage | room temperature (desiccate) |
| Mode of action | The mechanism of action of dapoxetine in premature ejaculation is presumed to be linked to the inhibition of neuronal reuptake of serotonin and the subsequent potentiation of the neurotransmitter's action at pre- and post-synaptic receptors. Dapoxetine is a centrally-acting SSRI that modulates serotonin levels in relevant areas such as the lateral paragigantocellular nucleus through inhibition of the serotonin transporter (SERT). This compound also decreases peak amplitude and accelerates the decay rate of current inactivation in a variety of voltage-gated K+ channels. |
